Zymeworks
ZYME
115 hedge funds and large institutions have $512M invested in Zymeworks in 2023 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 20 closing their positions.
100% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 20
72% more call options, than puts
Call options by funds: $2.46M | Put options by funds: $1.43M
33% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 27
20% more funds holding
Funds holding: 96 → 115 (+19)
14% more capital invested
Capital invested by funds: $450M → $512M (+$62.5M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.31% less ownership
Funds ownership: 90.84% → 88.53% (-2.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$22M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$6.1M |
| 3 |
Millennium Management
New York
|
+$4.65M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$4.36M |
| 5 |
HF
HRT Financial
New York
|
+$2.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$13.4M |
| 2 |
PA
Perceptive Advisors
New York
|
-$9.88M |
| 3 |
BC
Brookfield Corp
Toronto,
Ontario, Canada
|
-$5.83M |
| 4 |
SC
Sessa Capital
New York
|
-$5.82M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.81M |
ZYME Hedge Fund Activity: Q1 2023 in Review
115 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q1 2023, worth a combined $512M — up 14% from $450M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new ZYME positions and 20 closed out — a net gain of 20 holders — while 36 added to existing stakes and 27 trimmed.
The largest buyer was EcoR1 Capital, adding an estimated $22M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $13.4M sold.
- 115 institutional investors held Zymeworks (ZYME) as of Q1 2023, up from 96 in Q4 2022.
- Funds reported $512M of Zymeworks stock for Q1 2023, up 14% quarter-over-quarter.
- 40 funds opened new Zymeworks positions in Q1 2023 and 20 closed out, a net change of +20 holders.
- The largest Zymeworks buyer in Q1 2023 was EcoR1 Capital, an estimated $22M added.
- The largest Zymeworks seller in Q1 2023 was Baker Bros. Advisors, an estimated $13.4M sold.
Based on aggregated 13F filings for Q1 2023.